ATH 11.1% 0.4¢ alterity therapeutics limited

PBT2 for Middle Ear Infections

  1. 405 Posts.
    lightbulb Created with Sketch. 38
    Probably it is something new for PBT2.

    https://www.doherty.edu.au/news-events/news/dr-stephanie-neville-awarded-prestigious-fellowship


    This fellowship aims to address the issue of antibiotic resistance in otitis media-causing bacterial species.

    “This project builds on our discovery that the safe-for-human use ionophore, PBT2, is able to break antibiotic resistance in the bacteria that cause middle ear infections,” Dr Neville explained.“Ionophores are small compounds that are able shuttle high concentrations of metal ions into cells.“I plan to now investigate the in vivo efficacy of these ionophores in overcoming antibiotic resistance when they are co-administered with our current antibiotic arsenal.

    Apparently, quite a few activities for PBT2 are going on. Still nothing updates from ATH about PBT2, lol.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(11.1%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $1.528K 317.5K

Buyers (Bids)

No. Vol. Price($)
102 97511267 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31179254 15
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.